Harlan Weisman

Harlan Weisman is a highly experienced executive in the medical and biotechnology sectors, currently serving as Vice Chairman, President, and CEO of TFF Pharmaceuticals since September 2018, where the focus is on developing formulations for drug delivery to the lungs to minimize side effects. In addition, Harlan founded And-One Consulting, LLC to assist in global strategy formulation for medical product development, holds the position of Executive Chairman at 3D Bio Therapeutics, and serves on several boards, including the Center for Discovery and Innovation and CRG LP. Harlan's previous roles include Chairman and CEO of Flame Biosciences and a board member at Caelum Biosciences, contributing to advancements in treatments for rare diseases. Harlan's educational background includes an MD from Johns Hopkins Medical Institutions and a BA in Philosophy from the University of Maryland.